Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue.
Eur J Nucl Med Mol Imaging. 2017 Oct 17;:
Authors: Gains JE, Sebire NJ, Moroz V, Wheatley K, Gaze MN
Abstract PURPOSE: Neuroblastoma may be treated with molecular radiotherapy, (131)I meta-Iodobenzylguanidine and (177)Lu Lutetium DOTATATE, directed at distinct molecular targets: Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor (SSTR2), respectively.